芦笋 发表于 2025-3-23 10:17:15
http://reply.papertrans.cn/27/2682/268154/268154_11.png吞没 发表于 2025-3-23 15:05:36
Mit wem diskutiert man und wozu?Surgical procedures remain key diagnostic and therapeutic steps in the proper diagnosis and management of cutaneous malignancy. This chapter reviews surgical considerations necessary for optimizing the surgical approach to cutaneous malignancies.朝圣者 发表于 2025-3-23 18:43:46
Genodermatoses with Malignant Potential,Genodermatoses with malignant potential often manifest cutaneous findings as the presenting feature (Table 1). In most cases, the diagnosis can be made by clinical criteria or genetic testing. Prompt diagnosis is critical to initiate appropriate screening for malignancy.托人看管 发表于 2025-3-24 00:57:30
Surgical Approach to Cutaneous Malignancy with Systemic Implications,Surgical procedures remain key diagnostic and therapeutic steps in the proper diagnosis and management of cutaneous malignancy. This chapter reviews surgical considerations necessary for optimizing the surgical approach to cutaneous malignancies.松紧带 发表于 2025-3-24 06:06:33
https://doi.org/10.1007/978-3-030-53437-0Dermato-oncology; Paraneoplastic dermatoses; Cutaneous metastases; Drug reactions; Genodermatoses; MalignVEST 发表于 2025-3-24 08:43:17
http://reply.papertrans.cn/27/2682/268154/268154_16.pngfaultfinder 发表于 2025-3-24 13:08:01
http://reply.papertrans.cn/27/2682/268154/268154_17.pngpalette 发表于 2025-3-24 18:53:28
http://reply.papertrans.cn/27/2682/268154/268154_18.pngartifice 发表于 2025-3-24 20:47:41
https://doi.org/10.1007/978-3-8349-8686-3nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.jabber 发表于 2025-3-24 23:40:25
Dermatologic Adverse Effects of Anticancer Therapy I: General Principles,nticancer therapy. Reviewed are strategies and protocols for treating common symptoms and conditions experienced by these patients. Specific anticancer therapeutic classes are addressed in greater detail in the following three chapters.